PRQR — PROQR THRAPEUTICS N V

Ownership history in MACQUARIE GROUP LTD  ·  20 quarters on record

This page tracks every 13F SEC filing in which MACQUARIE GROUP LTD reported a position in PROQR THRAPEUTICS N V (PRQR). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.01% (2021 Q1)
Avg. % of fund
0.0%
First filed
2017 Q4
Last filed
2025 Q3
Quarters held
20
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 UNCHANGED 620,000 — 0% 0.00% $1.3M $2.13
2025 Q2 UNCHANGED 620,000 — 0% 0.00% $1.3M $2.04
2025 Q1 UNCHANGED 620,000 — 0% 0.00% $825K $1.33
2024 Q4 UNCHANGED 620,000 — 0% 0.00% $1.6M $2.65
2024 Q3 UNCHANGED 620,000 — 0% 0.00% $1.1M $1.82
2024 Q2 UNCHANGED 620,000 — 0% 0.00% $1.0M $1.66
2024 Q1 UNCHANGED 620,000 — 0% 0.00% $1.4M $2.29
2023 Q4 UNCHANGED 620,000 — 0% 0.00% $1.2M $1.98
2023 Q3 UNCHANGED 620,000 — 0% 0.00% $806K $1.30
2023 Q2 UNCHANGED 620,000 — 0% 0.00% $1.0M $1.62
10 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    PRQR price (monthly, adj. close)

Other funds also holding PRQR

As of 2025 Q4 — sorted by position size

Privium Fund Management B.V. 3Y 1.99% M28 Capital Management LP 3Y 1.5% DAFNA Capital Management LLC 3Y 7Y 0.74% Sio Capital Management, LLC 3Y 7Y 0.69% PLATINUM INVESTMENT MANAGEMENT LTD 3Y 7Y 0.58% Affinity Asset Advisors, LLC 3Y 0.28% Ikarian Capital, LLC 3Y 0.24% Kynam Capital Management, LP 3Y 0.2% Monaco Asset Management SAM 3Y 0.15% Palo Alto Investors LP 3Y 7Y 0.05%
← Back to MACQUARIE GROUP LTD Holdings